1-22811138-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017449.5(EPHB2):​c.811+26062C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 151,936 control chromosomes in the GnomAD database, including 7,725 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 7725 hom., cov: 31)

Consequence

EPHB2
NM_017449.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.158

Publications

2 publications found
Variant links:
Genes affected
EPHB2 (HGNC:3393): (EPH receptor B2) This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
EPHB2 Gene-Disease associations (from GenCC):
  • bleeding disorder, platelet-type, 22
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017449.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPHB2
NM_017449.5
MANE Select
c.811+26062C>T
intron
N/ANP_059145.2
EPHB2
NM_001309193.2
c.811+26062C>T
intron
N/ANP_001296122.1
EPHB2
NM_004442.7
c.811+26062C>T
intron
N/ANP_004433.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPHB2
ENST00000374630.8
TSL:1 MANE Select
c.811+26062C>T
intron
N/AENSP00000363761.3
EPHB2
ENST00000400191.7
TSL:1
c.811+26062C>T
intron
N/AENSP00000383053.3
EPHB2
ENST00000374632.7
TSL:1
c.811+26062C>T
intron
N/AENSP00000363763.3

Frequencies

GnomAD3 genomes
AF:
0.302
AC:
45829
AN:
151818
Hom.:
7727
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.214
Gnomad AMI
AF:
0.391
Gnomad AMR
AF:
0.379
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.743
Gnomad SAS
AF:
0.492
Gnomad FIN
AF:
0.284
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.294
Gnomad OTH
AF:
0.290
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.302
AC:
45835
AN:
151936
Hom.:
7725
Cov.:
31
AF XY:
0.310
AC XY:
23046
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.214
AC:
8840
AN:
41402
American (AMR)
AF:
0.380
AC:
5802
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
983
AN:
3470
East Asian (EAS)
AF:
0.743
AC:
3840
AN:
5170
South Asian (SAS)
AF:
0.490
AC:
2354
AN:
4802
European-Finnish (FIN)
AF:
0.284
AC:
2994
AN:
10554
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.294
AC:
19975
AN:
67946
Other (OTH)
AF:
0.291
AC:
615
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1554
3108
4662
6216
7770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.287
Hom.:
1194
Bravo
AF:
0.303
Asia WGS
AF:
0.533
AC:
1855
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.7
DANN
Benign
0.41
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4655117; hg19: chr1-23137631; API